American Chamber of Commerce in Romania

About AmCham Romania
Members
Business Advocacy
Events
Communication
Business Resources: AmCham HelpDesk; Best Practices; Business Guides & Reports; Useful Links
Members only section

Upcoming Events

05/29/2012 - Innovation and Leadership Meet in Your New Market Space
05/30/2012 - The Italian Chamber of Commerce for Romania, The American Chamber of Commerce in Romania and The Turkish Business Association – TIAD Announce ''Together –We Can do More''
05/31/2012 - STRATEGY - From Scenarios To Strategic Priorities: Getting Your Team Aligned: See the full calendar...

Committee Meetings

05/17/2012 - - Tourism committee meeting
05/22/2012 - Public Procurement and Structural Funds - committee meeting
05/23/2012 - Corporate Governance: See the full calendar...

COMMERCIAL NEWS U.S.A.
15 Years in Romania
Honored with Business Superbrands Award 2007/2008
European Council of American Chambers of Commerce in Europe
Foreign Commercial Service of the U.S. Embassy
U.S. Chamber of Commerce

Home I Business Resources I Business Guides & Reports

Beyond Borders - Global Biotechnology Report 2011

Source Ernst & Young

The global biotechnology industry delivered solid top- and bottom-line growth in 2010, with the industry achieving aggregate profitability for the second year in a row. Yet funding for research and development has grown increasingly scarce for the vast majority of firms in the sector, which tend to be pre-commercial stage companies that depend on years of funding to support drug development. This has placed new pressure on the traditional biotech business model, and may reshape how companies pursue R&D in the future, according to Beyond borders: global biotechnology report 2011, Ernst & Young’s 25th annual report on the biotech industry.